Tranquility Partners LLC Has $264,000 Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Tranquility Partners LLC raised its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 5.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 3,395 shares of the company’s stock after purchasing an additional 170 shares during the period. Tranquility Partners LLC’s holdings in Acadia Healthcare were worth $264,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of ACHC. Advisor Group Holdings Inc. increased its position in shares of Acadia Healthcare by 21.3% in the first quarter. Advisor Group Holdings Inc. now owns 4,111 shares of the company’s stock valued at $270,000 after acquiring an additional 721 shares during the last quarter. Bank of Montreal Can increased its position in Acadia Healthcare by 3.8% during the first quarter. Bank of Montreal Can now owns 7,263 shares of the company’s stock worth $477,000 after buying an additional 266 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Acadia Healthcare by 10.5% during the first quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 32,961 shares of the company’s stock worth $2,160,000 after buying an additional 3,143 shares during the last quarter. Great West Life Assurance Co. Can increased its position in Acadia Healthcare by 7.4% during the first quarter. Great West Life Assurance Co. Can now owns 48,461 shares of the company’s stock worth $3,262,000 after buying an additional 3,349 shares during the last quarter. Finally, Yousif Capital Management LLC increased its position in Acadia Healthcare by 2.1% during the first quarter. Yousif Capital Management LLC now owns 48,080 shares of the company’s stock worth $3,151,000 after buying an additional 982 shares during the last quarter.

Insider Buying and Selling at Acadia Healthcare

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. UBS Group boosted their price target on Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, February 28th. TD Cowen boosted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. Barclays assumed coverage on Acadia Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $100.00 price objective for the company. Royal Bank of Canada restated an “outperform” rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $91.22.

Acadia Healthcare Stock Performance

Shares of ACHC stock remained flat at $70.25 during trading on Thursday. The company had a trading volume of 50,475 shares, compared to its average volume of 556,294. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 0.48. The stock’s 50 day simple moving average is $79.62 and its 200-day simple moving average is $77.60. Acadia Healthcare Company, Inc. has a fifty-two week low of $66.49 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million during the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a positive return on equity of 11.21% and a negative net margin of 0.74%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.70 earnings per share. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 3.57 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.